Paper36908008
The expression of stanniocalcin-1, estrogen receptor and progesterone receptor in endometrioid endometrial cancer.
Erkılınç G and 6 others. Turk J Obstet Gynecol, 2023. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. The expression of stanniocalcin-1, estrogen receptor and progesterone receptor in endometrioid endometrial cancer. Papers, record 36908008. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36908008
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The expression of stanniocalcin-1, estrogen receptor and progesterone receptor in endometrioid endometrial cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27322879 | Stanniocalcin-1 expression in normal human endometrium and dysregulation in endometriosis. | Fertil Steril | 2016 | https://conductscience.org/library/papers/27322879 | PubMed |
| 2 | 22889960 | Expression of stanniocalcin 1 as a potential biomarker of gastric cancer. | Oncology | 2012 | https://conductscience.org/library/papers/22889960 | PubMed |
| 3 | 23770577 | Histological and immunohistochemical profiles predict lymph node status in women with low-intermediate risk endometrial cancer. | Gynecol Oncol | 2013 | https://conductscience.org/library/papers/23770577 | PubMed |
| 4 | 25740019 | Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma. | J Transl Med | 2015 | https://conductscience.org/library/papers/25740019 | PubMed |
| 5 | 32468698 | Expression, function and clinical application of stanniocalcin-1 in cancer. | J Cell Mol Med | 2020 | https://conductscience.org/library/papers/32468698 | PubMed |
| 6 | 19542542 | Is there a uniform basal endometrial gene expression profile during the implantation window in women who became pregnant in a subsequent ICSI cycle? | Hum Reprod | 2009 | https://conductscience.org/library/papers/19542542 | PubMed |
| 7 | 7489828 | A novel human cDNA highly homologous to the fish hormone stanniocalcin. | Mol Cell Endocrinol | 1995 | https://conductscience.org/library/papers/7489828 | PubMed |
| 8 | 30107158 | Culture characters, genetic background, estrogen/progesterone receptor expression, and tumorigenic activities of frequently used sixteen endometrial cancer cell lines. | Clin Chim Acta | 2019 | https://conductscience.org/library/papers/30107158 | PubMed |
| 9 | 12203221 | Endometrioid carcinoma of the endometrium with an invasive component of minimal deviation carcinoma. | Hum Pathol | 2002 | https://conductscience.org/library/papers/12203221 | PubMed |
| 10 | 31395281 | Do estrogen, progesterone, P53 and Ki67 receptor ratios determined from curettage materials in endometrioid-type endometrial carcinoma predict lymph node metastasis? | Curr Probl Cancer | 2020 | https://conductscience.org/library/papers/31395281 | PubMed |
| 11 | 1697729 | Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: Clinical and histologic correlations. | Am J Clin Pathol | 1990 | https://conductscience.org/library/papers/1697729 | PubMed |
| 12 | 26469082 | Stanniocalcin-1 Reduces Tumor Size in Human Hepatocellular Carcinoma. | PLoS One | 2015 | https://conductscience.org/library/papers/26469082 | PubMed |
| 13 | 18983480 | Development of targeted angiogenic medicine. | J Thromb Haemost | 2009 | https://conductscience.org/library/papers/18983480 | PubMed |
| 14 | 19267325 | Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1. | Stem Cells | 2009 | https://conductscience.org/library/papers/19267325 | PubMed |
| 15 | 17911007 | Prognostic significance of oestrogen receptor alpha (ERalpha) and beta (ERbeta), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas. | Eur J Cancer | 2007 | https://conductscience.org/library/papers/17911007 | PubMed |
| 16 | 20484106 | Stanniocalcin 1 and ovarian tumorigenesis. | J Natl Cancer Inst | 2010 | https://conductscience.org/library/papers/20484106 | PubMed |
| 17 | 27910065 | Pathology of Endometrial Carcinoma. | Adv Exp Med Biol | 2017 | https://conductscience.org/library/papers/27910065 | PubMed |
| 18 | 23932335 | Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial. | Eur J Cancer | 2013 | https://conductscience.org/library/papers/23932335 | PubMed |
| 19 | 32782542 | Stanniocalcin 1 is a prognostic biomarker in glioma. | Oncol Lett | 2020 | https://conductscience.org/library/papers/32782542 | PubMed |
| 20 | 29673664 | High throughput silencing identifies novel genes in endometrioid endometrial cancer. | Taiwan J Obstet Gynecol | 2018 | https://conductscience.org/library/papers/29673664 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41676249 | Hormone receptor status score is negatively correlated with adverse pathological features and serves as an independent prognostic factor in endometrial carcinoma. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/41676249 | PubMed |
| 40571316 | Elevated Stanniocalcin-1 Expression in Uveal Melanoma Predicts Poor Patient Prognosis. | Cancer Genomics Proteomics | 2025 | https://conductscience.org/library/papers/40571316 | PubMed |
| 39186548 | Stanniocalcin Protein Expression in Female Reproductive Organs: Literature Review and Public Cancer Database Analysis. | Endocrinology | 2024 | https://conductscience.org/library/papers/39186548 | PubMed |
| 38881902 | From mechanism to therapy: the journey of CD24 in cancer. | Front Immunol | 2024 | https://conductscience.org/library/papers/38881902 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 | NCBI Gene |
| NR4A1 | 3164 | PubTator's text mining | https://conductscience.org/library/genes/3164 | NCBI Gene |
| PGR | 5241 | PubTator's text mining | https://conductscience.org/library/genes/5241 | NCBI Gene |
| PTGER1 | 5731 | PubTator's text mining | https://conductscience.org/library/genes/5731 | NCBI Gene |
| STC1 | 6781 | PubTator's text mining | https://conductscience.org/library/genes/6781 | NCBI Gene |
| STC2 | 8614 | PubTator's text mining | https://conductscience.org/library/genes/8614 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36908008
GET https://conductscience.org/api/papers/v1/36908008/references?page=2